{
    "clinical_study": {
        "@rank": "141290", 
        "arm_group": [
            {
                "arm_group_label": "Egg albumin-based protein supplement", 
                "arm_group_type": "Experimental", 
                "description": "Powder form, dosage 30 g daily, duration 6 months"
            }, 
            {
                "arm_group_label": "Renal-specific oral supplement", 
                "arm_group_type": "Active Comparator", 
                "description": "Liquid form, dosage 237 ml (one can) daily, duration 6 months"
            }
        ], 
        "brief_summary": {
            "textblock": "Malnutrition is seen frequently in hemodialysis units in most developing countries.\n      Malnutrition increases morbidity and mortality in this population and its treatment improves\n      patient survival and health status The purpose of this study is to compare two strategies to\n      improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml)\n      versus egg albumin-based protein supplement (30 g) on a daily basis.\n\n      This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment\n      (SGA) in addition to most used biochemical markers to determine nutritional status."
        }, 
        "brief_title": "Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients", 
        "condition": [
            "Protein-Energy Malnutrition", 
            "Kidney Failure, Chronic", 
            "Hemodialysis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Kidney Failure, Chronic", 
                "Protein-Energy Malnutrition", 
                "Renal Insufficiency", 
                "Malnutrition"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chronic Kidney Disease in Hemodialysis\n\n        Exclusion Criteria:\n\n          -  Infection\n\n          -  Liver insufficiency\n\n          -  Cancer or neoplasia\n\n          -  Acquired immunodeficiency syndrome\n\n          -  Intestinal malabsorption syndrome"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981083", 
            "org_study_id": "217B500602013026"
        }, 
        "intervention": [
            {
                "arm_group_label": "Egg albumin-based protein supplement", 
                "intervention_name": "Egg albumin-based protein supplement", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Pure ProEgg"
            }, 
            {
                "arm_group_label": "Renal-specific oral supplement", 
                "intervention_name": "Renal-specific oral supplement", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Enterex Renal"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Protein-Energy Malnutrition", 
            "Chronic Kidney Disease", 
            "Malnutrition-Inflammation Score", 
            "Subjective Global Assessment", 
            "Hemodialysis", 
            "Egg albumin"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toluca", 
                    "country": "Mexico", 
                    "state": "Estado de Mexico", 
                    "zip": "50010"
                }, 
                "name": "Centro Medico Lic. Adolfo L\u00f3pez Mateos"
            }, 
            "investigator": {
                "last_name": "Rafael Gonzalez-Toledo, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Open Label, Controlled Clinical Trial of Egg Albumin-Based Protein Supplement Versus Renal Specific Oral Supplement in Hemodialysis Patients", 
        "overall_contact": {
            "email": "rtoledo29@yahoo.com.mx", 
            "last_name": "Rafael Gonzalez-Toledo, MD", 
            "phone": "52(722)2760860", 
            "phone_ext": "90457"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Mexico: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in Malnutrition-Inflammation Score", 
                "safety_issue": "No", 
                "time_frame": "Bimonthly, up to six months"
            }, 
            {
                "measure": "Change in Subjective Global Assessment", 
                "safety_issue": "No", 
                "time_frame": "Bimonthly, up to six months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981083"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centro Medico Lic Adolfo Lopez Mate", 
            "investigator_full_name": "Rafael Gonzalez-Toledo", 
            "investigator_title": "Affiliated Physician of the Nephrology Service", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Centro Medico Lic Adolfo Lopez Mate", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centro Medico Lic Adolfo Lopez Mate", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}